Market Trends Heron Therapeutics GAAP EPS of $0.02 beats by $0.05, revenue of $40.78M beats by $3.41M (NASDAQ:HRTX)By admin8996erT0allFebruary 27, 2025 Heron Therapeutics press release (NASDAQ:HRTX): Q4 GAAP EPS of $0.02 beats by $0.05. Revenue of $40.78M (+19.2% Y/Y) beats by…
